Advertisment

Insulin-R

USFDA issues CRL for proposed biosimilar Insulin-R: Biocon

USFDA issues CRL for proposed biosimilar Insulin-R: Biocon

Biotechnology major Biocon on Saturday said the US health regulator has issued a complete response letter for Biocon Biologics' application for Insulin-R, a pr...
Advertisment
Subscribe